AI & Technology

Corporate stories about AI & Technology across 3BL's network.

Latest in AI & Technology

Black & Veatch Collaborates With Hexagon on Intelligent Tools
Black & Veatch, Hexagon PPM announce a new technology partnership that will allow the global EPC leader to see faster, more seamless communication, quicker updates and smoother integration, helping to advance engineering design into the digital age.
Smart Field Tests for Smarter Airports
Air travel will get a facelift in the near future thanks to modern technologies like the Internet of Things (IoT) and 5G. Smart airports will improve passengers’ travel experiences and make operations more efficient. Improvements include...
The Road to a Vaccine, Season 2, Ep. 2: How New COVID-19 Outbreaks Are Impacting a Global Return to Normal
Lisa Ling talks with Dr. Francis Collins, Director, NIH about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means
Black & Veatch Salutes US Water Prize 2020 Winners
As a sponsor of the US Water Prize 2020, global water infrastructure and solutions leader Black & Veatch salutes the latest recipients of the award recognizing people and organizations advancing innovations in water management and a more sustainable water future.
CNH Industrial Electrifies the Construction Industry With "ProjectZeus"
CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) is continuously pushing the boundaries of what is possible with clean energy and alternative fuel solutions.
CNH
Making Juice, Nectars and Still Drinks Using 50% Less Water and Nearly 70% Less Energy. No Catch.
In a world where there is an urgent need to protect our planet and meet consumer expectations for environmentally friendly options, sustainability cannot be a mere sweetener for the JNSD industry’s mission to make high-quality beverages
Novartis lance le tout premier portefeuille de médicaments à but non lucratif pour le traitement symptomatique du COVID-19
Novartis a annoncé, aujourd’hui, une nouvelle initiative visant à donner accès aux patients de pays à faibles revenus et à revenus intermédiaires (PFR; PRI) à des médicaments abordables pour traiter les principaux symptômes du COVID-19 – un besoin qui s’avère crucial en l’absence de vaccin ou de traitement curatif.